16.40
price up icon1.11%   0.18
 
loading

Finanzdaten der Rallybio Corp-Aktie (RLYB)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
100.00%
-
0.212 0.222 0.212 0.212
Operating Expenses
36.80%
5.653
8.945 6.634 7.137 10.27
Depreciation and Amortization
33.33%
0.002
0.003 0.003 0.035 0.026
Operating Income/Loss
35.27%
-5.653
-8.733 -6.412 -6.925 -10.06
Nonoperating Income/Loss
11,030%
50.64
0.455 0.56 22.94 0.641
Income/Loss From Equity Method Investments
-
- - - -0.287
Income/Loss From Continuing Operations Before Tax
643.48%
44.99
-8.278 -5.852 16.02 -9.416
Income Tax Expense/Benefit
1.324
- - - -
Net Income/Loss
627.48%
43.66
-8.278 -5.852 16.02 -9.703
Basic Average Shares
0.19%
5.6991
5.6886 - 45.06 44.84
Diluted Average Shares
1.92%
5.7979
5.6886 - 45.06 44.84
Basic Earnings Per Share
624.66%
7.66
-1.46 - 0.36 -0.22
Diluted Earnings Per Share
615.75%
7.53
-1.46 - 0.36 -0.22
$5.86
price down icon 0.68%
$8.10
price up icon 3.98%
$8.38
price up icon 0.12%
DNA DNA
$9.71
price down icon 3.00%
$11.85
price down icon 6.10%
$10.49
price down icon 2.24%
Kapitalisierung:     |  Volumen (24h):